Digital PCR and qPCR Market: Growth, Size, Share, and Trends

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029

Report Code: BT 3161 Jul, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global digital PCR market growth forecasted to transform from $10.0 billion in 2024 to $14.8 billion by 2029, driven by a CAGR of 8.1%. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery,  and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics. However, challenges such as time consuming methodology involving in sample handling and post-PCR analysis, and lack of accuracy & standardization in protocol may hinder the market's growth.

Digital PCR Market Trends

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

To know about the assumptions considered for the study, Request for Free Sample Report

Attractive Opportunities in the Digital PCR Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Global Digital PCR Market Dynamics

DRIVER: Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics

dPCR and qPCR technologies offer high sensitivity, specificity, and rapid results, making them ideal for POC applications where timely and accurate diagnostics are crucial. The ability to perform on-the-spot testing in various settings, such as clinics, hospitals, and remote locations, enhances disease management and patient outcomes. The demand for POC diagnostics has surged, especially in the wake of global health crises like the COVID-19 pandemic, highlighting the need for decentralized testing solutions. The PoC testing market has grown significantly over the last few years due to the increasing adoption of PoC testing products in home care settings and hospitals. The convenience of these tools has greatly driven their adoption, particularly given the rising prevalence of infectious diseases, technological advancements in PoC testing products, the growing patient awareness of PoC testing, the shortage of technicians to conduct conventional lab tests, and the rising number of Clinical Laboratory Improvement Amendment (CLIA) approvals for PoC tests.

RESTRAINT: Unfavorable reimbursement scenario for diagnostic companies

Insurance coverage for PCR tests varies widely by region and by provider. Inconsistent policies can lead to out-of-pocket expenses for patients, making them less likely to opt for these advanced diagnostic tests. Insurers may cover only certain types of PCR tests or only under specific conditions, restricting the use of dPCR and qPCR for broader diagnostic applications. Even when PCR tests are covered, the reimbursement rates may be low. This can result in healthcare providers being reluctant to offer these tests due to the financial burden of not covering the costs of the tests and associated procedures. Low reimbursement rates can discourage investment in new PCR technologies and the development of innovative applications, as companies may not see a sufficient return on investment. For instance, In March 2023, the Centers for Medicare & Medicaid Services’ (CMS), through its local contractors (known as Medicare Administrative Contractors or MACs) issued revised billing instructions for blood test for organ transplant in response to improper billing and overutilization. Billing instructions help health care providers understand when and how to bill Medicare for a covered service. Moreover, in February 2024 the MACs updated these instructions to clarify that these tests remain available to patients when medically necessary and ordered by a physician. furthermore CMS’s Medicare Administrative Contractors (MACs) have removed and replaced the March 2023, billing article. The new article restores the table of solid organ allograft rejection tests for indications that meet the coverage criteria, as requested by interested parties, and removes explanatory language that may have confused physicians and patients.

OPPORTUNITY: Growing significance of RT-PCR based companion diagnostics in drug development process

RT-PCR based companion diagnostics play a crucial role in personalized medicine by enabling the identification of specific genetic mutations, gene expressions, or biomarkers that influence a patient's response to a particular drug. This allows for the development of targeted therapies tailored to individual patients, improving treatment efficacy and minimizing adverse effects. Companion diagnostics using RT-PCR can identify predictive biomarkers that indicate how well a patient will respond to a specific treatment. This helps in selecting the right patients for clinical trials and ensures that only those likely to benefit from the therapy are included, thereby increasing the success rates of clinical trials. RT-PCR can also detect biomarkers associated with adverse drug reactions, aiding in the exclusion of patients who may experience severe side effects, enhancing patient safety, and improving overall treatment outcomes. Regulatory agencies such as the FDA often require companion diagnostics for the approval of targeted therapies. RT-PCR based diagnostics provide robust and reproducible results that meet regulatory standards, facilitating the approval process for new drugs. in 2019, QIAGEN Manchester Ltd., has received US FDA approval for therascreen FGFR RGQ RT-PCR Kit for the detection of Urothelial Cancer – Tissue.

CHALLENGE: Availability of alternative technologies for disease diagnosis

The availability of alternative technologies for disease diagnosis poses a significant challenge for the qPCR and dPCR markets. Advanced diagnostic methods such as next-generation sequencing (NGS), CRISPR-based diagnostics, and immunoassays offer different advantages like higher throughput, broader detection capabilities, and often lower costs. These technologies can provide comprehensive genetic profiling, rapid results, and cost-effective solutions, making them attractive alternatives to PCR-based methods. As these alternative technologies continue to advance and become more accessible, they could potentially reduce the demand for qPCR and dPCR, impacting market growth and prompting PCR technology providers to innovate and demonstrate the unique value of their solutions in a competitive diagnostic landscape.Techniques like ELISA (enzyme-linked immunosorbent assay) are well-established for detecting proteins and other biomarkers associated with diseases. They offer an alternative diagnostic approach that doesn’t require nucleic acid amplification, which can be quicker and less resource-intensive for certain applications. Some alternative technologies can be more cost-effective compared to qPCR and dPCR, especially when considering the cost of reagents, equipment, and the need for skilled personnel.

Global Digital PCR Market Ecosystem Analysis

The digital PCR (dPCR) and real-time PCR (qPCR) market ecosystem comprises raw material suppliers, digital PCR (dPCR) and real-time PCR (qPCR) product manufacturers, and end users such as hospitals and diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, CROs and CDMOs, forensic laboratories, and others

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Ecosystem

The droplet digital PCR instrument segment of the digital PCR industry under DPCR instrument dominated digital PCR market in 2023.

Based on instrument, the digital PCR market is segmented into droplet digital PCR, chip-based digital PCR and Beaming digital PCR. In 2023, droplet digital PCR segment dominated the market. Droplet digital PCR (dDPCis) is the modified form of real-time PCR, which utilizes a water-oil emulsion droplet system. Each water droplet separates template DNA molecules into individual PCR reactions. As a result, thousands of independent amplification events can occur within a single sample. The growth of the ddPCR instruments market will primarily be driven by the procedural benefits of ddPCR, like high accuracy and time efficiency. In addition, ddPCR is more tolerant to common inhibitors present in the matrices used in the viral vector process. The ddPCR segment is experiencing significant growth due to its precise nucleic acid quantification capabilities, expanding oncology and liquid biopsy diagnostics applications, and increasing demand for high-sensitivity genetic analysis in clinical & research settings.

The gene expression segment under research application segment dominated the digital PCR industry in 2023.

Based on research application, the digital PCR market is segmented into single cell analysis, stem cell research, gene expression and other research application. In 2023, the gene expression segment accounted for the largest share of the digital PCR (dPCR) and real-time PCR (qPCR) market. The primary driving factors for the use of qPCR in gene expression studies are the need for precise and sensitive quantification of gene expression and the increasing importance of personalized medicine and biomarker discovery. qPCR's high sensitivity and specificity make it an ideal tool for these applications.

North America was the largest regional market for the digital PCR industry in 2023.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global digital PCR market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. North America was the largest segment in 2023 in the digital PCR (dPCR) and real-time PCR (qPCR) market, followed by Europe and the Asia Pacific. Factors such as the presence of key market players such as Danaher Corporation (US) and Thermo Fisher Scientific Inc. (US) in the region, rising demand for qPCR and dPCR product for early and accurate disease diagnosis due to increasing patient population suffering from life-threatening disease.

Scope of the Digital PCR Industry

Report Metric

Details

Market Revenue in 2024

$10.0 billion

Projected Revenue by 2029

$14.8 billion

Revenue Rate

Poised to Grow at a CAGR of 8.1%

Market Driver

Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics

Market Opportunity

Growing significance of RT-PCR based companion diagnostics in drug development process

This report categorizes the digital PCR market to forecast revenue and analyze trends in each of the following submarkets:

By Offering
  • QPCR
    • QPCR Product
      • QPCR Reagents and Consumables
      • QPCR Instruments
    • QPCR Software
    • QPCR Service
  • DPCR
    • DPCR Products
      • DPCR Reagents and Consumables
      • DPCR Instruments
        • Droplet Digital PCR
        • Chip-based PCR
        • Beaming Digital PCR
    • DPCR Software
    • DPCR Service
By Application
  • QPCR Application
    • Clinical Applications
      • Infectious Disease Testing
      • Oncology Testing
      • Blood Screening
      • Transplant Diagnostics
      • Other Clinical Applications
    • Research Applications
    • Forensic Applications
    • Environmental Applications
    • Other Applications
  • DPCR Applications
    • Clinical Applications
      • Infectious Disease Testing
      • Oncology Testing
      • Blood Screening
      • Transplant Diagnostics
      • Other Clinical Applications
    • Research Applications
      • Single Cell Analysis
      • Stem Cell Research
      • Gene Expression
      • Other Research Application
    • Forensic Applications
    • Environmental Applications
    • Other Applications
By End User
  • QPCR End Users
    • Hospitals and Diagnostic Laboratories
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • CROs and CDMOs
    • Forensic Laboratories
    • Other End Users
  • DPCR End Users
    • Hospitals and Diagnostic Laboratories
    • Academic and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • CROs and CDMOs
    • Forensic Laboratories
    • Other End Users
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East
    • GCC
      • Saudi Arabia
      • UAE
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of Digital PCR Market

  • In May 2024, Qiagen N.V. entered into a cooperative R&D agreement (CRADA) with the US Federal Bureau of Investigation (FBI) to develop a novel test for its QIAcuity digital PCR devices that will boost forensics by improving the quantification of DNA in human samples.
  • In March 2024, F. Hoffmann-La Roche Ltd, has received the US Food and Drug approval for its cobas Malaria test for use on the cobas 6800/8800 systems.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION 
2 RESEARCH METHODOLOGY 
3 EXECUTIVE SUMMARY 
 
4 PREMIUM INSIGHTS (Page No. - 72)
    4.1 DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW 
    4.2 ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024) 
    4.3 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET 
 
5 MARKET OVERVIEW (Page No. - 75)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of infectious diseases and genetic disorders
                    5.2.1.2 Increasing advancements in PCR technologies
                    5.2.1.3 Increasing applications of PCR in biomarker discovery
                    5.2.1.4 Growing focus on dPCR and qPCR technologies for POC diagnostics
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of dPCR instruments
                    5.2.2.2 Technical limitations associated with qPCR and dPCR
                    5.2.2.3 Unfavorable reimbursements for diagnostic companies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth potential of emerging markets
                    5.2.3.2 Integration of qPCR and dPCR with NGS
                    5.2.3.3 Growing significance of RT-PCR-based companion diagnostics in drug development
           5.2.4 CHALLENGES
                    5.2.4.1 Time constraints associated with sample handling
                    5.2.4.2 Inadequate protocols for accuracy & standardization
                    5.2.4.3 Availability of alternative technologies
    5.3 PORTER’S FIVE FORCES ANALYSIS 
           5.3.1 DEGREE OF COMPETITION
           5.3.2 BARGAINING POWER OF SUPPLIERS
           5.3.3 BARGAINING POWER OF BUYERS
           5.3.4 THREAT OF SUBSTITUTES
           5.3.5 THREAT OF NEW ENTRANTS
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.5 TECHNOLOGY ANALYSIS 
           5.5.1 KEY TECHNOLOGIES
           5.5.2 COMPLEMENTARY TECHNOLOGIES
           5.5.3 ADJACENT TECHNOLOGIES
    5.6 SUPPLY CHAIN ANALYSIS 
    5.7 VALUE CHAIN ANALYSIS 
    5.8 PRICING ANALYSIS 
    5.9 ECOSYSTEM ANALYSIS 
           5.9.1 DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS
           5.9.2 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
           5.9.3 DPCR AND QPCR MARKET: ROLE OF END USERS
           5.9.4 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
    5.10 PATENT ANALYSIS 
           5.10.1 PATENT METHODOLOGY
           5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
           5.10.3 INNOVATION & PATENT APPLICATIONS
           5.10.4 TOP APPLICANTS
    5.11 KEY CONFERENCES AND EVENTS (2024−2025) 
    5.12 REGULATORY LANDSCAPE 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.12.2 REGULATORY SCENARIO
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
           5.13.2 KEY BUYING CRITERIA AMONG END USERS
    5.14 INVESTMENT & FUNDING SCENARIO 
    5.15 TRADE ANALYSIS 
 
6 DPCR AND QPCR MARKET, BY OFFERING (Page No. - 113)
    6.1 INTRODUCTION 
    6.2 QPCR OFFERINGS 
           6.2.1 QPCR PRODUCTS
                    6.2.1.1 qPCR reagents & consumables
                               6.2.1.1.1 Recurring consumption of detection agents to drive market
                    6.2.1.2 qPCR instruments
                               6.2.1.2.1 Advancements in instrument design to drive market
           6.2.2 QPCR SOFTWARE
                    6.2.2.1 Rising demand for specialized analysis software to support market growth
           6.2.3 QPCR SERVICES
                    6.2.3.1 Growing requirement for maintenance and calibration of PCR instruments to fuel market
    6.3 DPCR OFFERINGS 
           6.3.1 DPCR PRODUCTS
                    6.3.1.1 DPCR reagents & consumables
                               6.3.1.1.1 Availability of novel dPCR reagents to propel market
                    6.3.1.2 DPCR instruments
                               6.3.1.2.1 Droplet digital PCR
                                             6.3.1.2.1.1 High accuracy and time efficiency benefits to fuel uptake
                               6.3.1.2.2 Chip-based digital PCR
                                             6.3.1.2.2.1 High-throughput capabilities to boost demand
                               6.3.1.2.3 Beaming digital PCR
                                             6.3.1.2.3.1 Growing applications in oncology diagnostics to support market growth
           6.3.2 DPCR SOFTWARE
                    6.3.2.1 Ability to enhance workflow efficiency to drive market
           6.3.3 DPCR SERVICES
                    6.3.3.1 Rising need for application-specific guidance to support market growth
 
7 DPCR AND QPCR MARKET, BY APPLICATION (Page No. - 161)
    7.1 INTRODUCTION 
    7.2 QPCR APPLICATIONS 
           7.2.1 CLINICAL APPLICATIONS
                    7.2.1.1 Infectious disease testing
                               7.2.1.1.1 Wide utilization in pathogen testing to fuel market
                    7.2.1.2 Oncology testing
                               7.2.1.2.1 High uptake in tumor screening & classification to boost demand
                    7.2.1.3 Blood screening
                               7.2.1.3.1 Elimination of post-amplification processing to drive market
                    7.2.1.4 Transplant diagnostics
                               7.2.1.4.1 Growing preference for genome-based products to fuel market
                    7.2.1.5 Other clinical applications
           7.2.2 RESEARCH APPLICATIONS
                    7.2.2.1 Single-cell analysis
                               7.2.2.1.1 Growing need for high-resolution molecular data to drive market
                    7.2.2.2 Stem cell research
                               7.2.2.2.1 Growing focus on regenerative medicine to boost demand
                    7.2.2.3 Gene expression
                               7.2.2.3.1 Precise quantification requirements to support market growth
                    7.2.2.4 Other research applications
           7.2.3 FORENSIC APPLICATIONS
                    7.2.3.1 Ability to analyze genetic fingerprinting and biological samples to propel market
           7.2.4 ENVIRONMENTAL APPLICATIONS
                    7.2.4.1 Development of specialized assays for environmental monitoring to drive market
           7.2.5 OTHER QPCR APPLICATIONS
    7.3 DPCR APPLICATIONS 
           7.3.1 CLINICAL APPLICATIONS
                    7.3.1.1 Infectious disease testing
                               7.3.1.1.1 Accuracy and precision capabilities to boost demand
                    7.3.1.2 Oncology testing
                               7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market
                    7.3.1.3 Blood screening
                               7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth
                    7.3.1.4 Transplant diagnostics
                               7.3.1.4.1 Low market availability to restrain market
                    7.3.1.5 Other clinical applications
           7.3.2 RESEARCH APPLICATIONS
                    7.3.2.1 High uptake by pharma & biotech companies for drug screening to drive market
                    7.3.2.2 Single-cell analysis
                               7.3.2.2.1 dDPCR compatibility with one-step RT-PCR to boost demand
                    7.3.2.3 Stem cell research
                               7.3.2.3.1 Growing need for reliable tools to assess stem cell quality & potency to boost demand
                    7.3.2.4 Gene expression
                               7.3.2.4.1 Increasing demand for accurate quantification methods in personalized medicine to drive market
                    7.3.2.5 Other research applications
           7.3.3 FORENSIC APPLICATIONS
                    7.3.3.1 DNA profiling benefits to support market growth
           7.3.4 ENVIRONMENTAL APPLICATIONS
                    7.3.4.1 Increasing demand for wastewater surveillance to drive market
           7.3.5 OTHER DPCR APPLICATIONS
 
8 DPCR AND QPCR MARKET, BY END USER (Page No. - 250)
    8.1 INTRODUCTION 
    8.2 QPCR END USERS 
           8.2.1 HOSPITALS AND DIAGNOSTIC LABORATORIES
                    8.2.1.1 Growing uptake in disease diagnostics to drive market
           8.2.2 ACADEMIC & RESEARCH INSTITUTES
                    8.2.2.1 Growing focus on genetic & molecular studies to boost demand
           8.2.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
                    8.2.3.1 Rising focus on drug discovery & development to propel market
           8.2.4 CROS AND CDMOS
                    8.2.4.1 Increasing outsourcing of drug development activities by pharma companies to boost demand
           8.2.5 FORENSIC LABORATORIES
                    8.2.5.1 Growing trend of laboratory automation to drive market
           8.2.6 OTHER END USERS
    8.3 DPCR END USERS 
           8.3.1 HOSPITALS AND DIAGNOSTIC LABORATORIES
                    8.3.1.1 High uptake in genetic testing and embryo DNA profiling to drive market
           8.3.2 ACADEMIC & RESEARCH INSTITUTES
                    8.3.2.1 Rising R&D funding investments to support market growth
           8.3.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
                    8.3.3.1 High uptake in toxicity & clinical studies to drive market
           8.3.4 CROS AND CDMOS
                    8.3.4.1 Rising number of clinical trials to support market growth
           8.3.5 FORENSIC LABORATORIES
                    8.3.5.1 Development of advanced dPCR assays to support market growth
           8.3.6 OTHER END USERS
 
9 DPCR AND QPCR MARKET, BY REGION (Page No. - 289)
    9.1 INTRODUCTION 
    9.2 NORTH AMERICA 
           9.2.1 NORTH AMERICA: RECESSION IMPACT
           9.2.2 US
                    9.2.2.1 Rising adoption of advanced technologies to drive market
           9.2.3 CANADA
                    9.2.3.1 Supportive government initiatives for genomics research to drive market
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
           9.3.2 GERMANY
                    9.3.2.1 Rising healthcare expenditure and favorable reimbursements for diagnostic procedures to boost demand
           9.3.3 UK
                    9.3.3.1 Growing focus on genomics research to drive market
           9.3.4 FRANCE
                    9.3.4.1 Supportive government regulations for diagnostic assay procedures to drive market
           9.3.5 ITALY
                    9.3.5.1 Increasing funding investments for development of innovative therapies to fuel market
           9.3.6 SPAIN
                    9.3.6.1 Rising funding investments for R&D to support market growth
           9.3.7 REST OF EUROPE
    9.4 ASIA PACIFIC 
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
           9.4.2 CHINA
                    9.4.2.1 Modernization of healthcare infrastructure to propel market
           9.4.3 JAPAN
                    9.4.3.1 Rising number of oncology research activities to drive market
           9.4.4 INDIA
                    9.4.4.1 Growth in pharmaceutical industry to drive market
           9.4.5 AUSTRALIA
                    9.4.5.1 Growth in biopharmaceuticals market sector to fuel market
           9.4.6 SOUTH KOREA
                    9.4.6.1 Development of advanced PCR-based diagnostic instruments to support market growth
           9.4.7 REST OF ASIA PACIFIC
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
           9.5.2 BRAZIL
                    9.5.2.1 High burden of chronic and infectious diseases to propel market
           9.5.3 MEXICO
                    9.5.3.1 Growing availability of advanced diagnostic instruments to boost demand
           9.5.4 REST OF LATIN AMERICA
    9.6 MIDDLE EAST 
           9.6.1 MIDDLE EAST: RECESSION IMPACT
           9.6.2 GCC COUNTRIES
                    9.6.2.1 Kingdom of Saudi Arabia
                               9.6.2.1.1 Growing healthcare expenditure to boost market
                    9.6.2.2 United Arab Emirates
                               9.6.2.2.1 High production of biopharmaceuticals to support market growth
                    9.6.2.3 Other GCC Countries
           9.6.3 REST OF MIDDLE EAST
    9.7 AFRICA 
           9.7.1 INCREASING FOCUS ON CANCER DIAGNOSTICS TO SUPPORT MARKET GROWTH
           9.7.2 AFRICA: RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 470)
     10.1 INTRODUCTION 
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
     10.3 REVENUE ANALYSIS 
     10.4 MARKET SHARE ANALYSIS 
     10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
             10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        10.5.5.1 Overall footprint
                        10.5.5.2 Offering footprint
                        10.5.5.3 Application footprint
                        10.5.5.4 End-user footprint
                        10.5.5.5 Region footprint
     10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 RESPONSIVE COMPANIES
             10.6.3 DYNAMIC COMPANIES
             10.6.4 STARTING BLOCKS
             10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
     10.7 COMPANY VALUATION & FINANCIAL METRICS 
     10.8 BRAND/PRODUCT COMPARISON ANALYSIS 
     10.9 COMPETITIVE SCENARIO 
             10.9.1 PRODUCT LAUNCHES & APPROVALS
             10.9.2 DEALS
             10.9.3 EXPANSIONS
 
11 COMPANY PROFILES (Page No. - 493)
     11.1 KEY PLAYERS 
             11.1.1 DANAHER CORPORATION
                        11.1.1.1 Business overview
                        11.1.1.2 Products offered
                        11.1.1.3 Recent developments
                                     11.1.1.3.1 Product launches & approvals
                                     11.1.1.3.2 Deals
                        11.1.1.4 MnM view
                                     11.1.1.4.1 Key strengths
                                     11.1.1.4.2 Strategic choices
                                     11.1.1.4.3 Weaknesses & competitive threats
             11.1.2 F. HOFFMANN-LA ROCHE LTD.
                        11.1.2.1 Business overview
                        11.1.2.2 Products offered
                        11.1.2.3 Recent developments
                                     11.1.2.3.1 Product launches & approvals
                                     11.1.2.3.2 Deals
                        11.1.2.4 MnM view
                                     11.1.2.4.1 Key strengths
                                     11.1.2.4.2 Strategic choices
                                     11.1.2.4.3 Weaknesses & competitive threats
             11.1.3 THERMO FISHER SCIENTIFIC INC.
                        11.1.3.1 Business overview
                        11.1.3.2 Products offered
                        11.1.3.3 Recent developments
                                     11.1.3.3.1 Product launches & approvals
                                     11.1.3.3.2 Deals
                        11.1.3.4 MnM view
                                     11.1.3.4.1 Key strengths
                                     11.1.3.4.2 Strategic choices
                                     11.1.3.4.3 Weaknesses & competitive threats
             11.1.4 MERCK KGAA
                        11.1.4.1 Business overview
                        11.1.4.2 Products offered
             11.1.5 QIAGEN N.V.
                        11.1.5.1 Business overview
                        11.1.5.2 Products offered
                        11.1.5.3 Recent developments
                                     11.1.5.3.1 Product launches & approvals
                                     11.1.5.3.2 Deals
             11.1.6 BIO-RAD LABORATORIES, INC.
                        11.1.6.1 Business overview
                        11.1.6.2 Products offered
                        11.1.6.3 Recent developments
                                     11.1.6.3.1 Product launches & approvals
                                     11.1.6.3.2 Deals
             11.1.7 AGILENT TECHNOLOGIES, INC.
                        11.1.7.1 Business overview
                        11.1.7.2 Products offered
                        11.1.7.3 Recent developments
                                     11.1.7.3.1 Product launches & approvals
                                     11.1.7.3.2 Expansions
             11.1.8 TAKARA BIO INC.
                        11.1.8.1 Business overview
                        11.1.8.2 Products offered
                        11.1.8.3 Recent developments
                                     11.1.8.3.1 Deals
             11.1.9 BECTON, DICKINSON, AND COMPANY
                        11.1.9.1 Business overview
                        11.1.9.2 Products offered
                        11.1.9.3 Recent developments
                                     11.1.9.3.1 Product launches & approvals
                                     11.1.9.3.2 Deals
             11.1.10 ABBOTT LABORATORIES
                        11.1.10.1 Business overview
                        11.1.10.2 Products offered
                        11.1.10.3 Recent developments
                                     11.1.10.3.1 Product launches & approvals
             11.1.11 PROMEGA CORPORATION
                        11.1.11.1 Business overviews
                        11.1.11.2 Products offered
                        11.1.11.3 Recent developments
                                     11.1.11.3.1 Product launches & approvals
             11.1.12 MERIDIAN BIOSCIENCE
                        11.1.12.1 Business overview
                        11.1.12.2 Products offered
                        11.1.12.3 Recent developments
                                     11.1.12.3.1 Product launches & approvals
                                     11.1.12.3.2 Deals
             11.1.13 ENDRESS+HAUSER GROUP SERVICES AG
                        11.1.13.1 Business overview
                        11.1.13.2 Products offered
                        11.1.13.3 Recent developments
                                     11.1.13.3.1 Product launches & approvals
                                     11.1.13.3.2 Deals
             11.1.14 BIOMÉRIEUX
                        11.1.14.1 Business overview
                        11.1.14.2 Products offered
                        11.1.14.3 Recent developments
                                     11.1.14.3.1 Product launches & approvals
             11.1.15 EPPENDORF AG
                        11.1.15.1 Business overviews
                        11.1.15.2 Products offered
             11.1.16 QUIDELORTHO CORPORATION
                        11.1.16.1 Business overview
                        11.1.16.2 Products offered
                        11.1.16.3 Recent developments
                                     11.1.16.3.1 Product launches & approvals
                                     11.1.16.3.2 Deals
             11.1.17 ENZO BIOCHEM INC.
                        11.1.17.1 Business overview
                        11.1.17.2 Products offered
                        11.1.17.3 Recent developments
                                     11.1.17.3.1 Deals
             11.1.18 LEPU MEDICAL TECHNOLOGY CO., LTD.
                        11.1.18.1 Business overview
                        11.1.18.2 Products offered
             11.1.19 SYSMEX CORPORATION
                        11.1.19.1 Business overview
                        11.1.19.2 Products offered
     11.2 STARTUP/SME PLAYERS 
             11.2.1 BIOCARTIS
             11.2.2 STILLA
             11.2.3 ANTYLIA SCIENTIFIC
             11.2.4 BIONEER CORPORATION
             11.2.5 STANDARD BIOTOOLS
             11.2.6 SEEGENE INC.
             11.2.7 GENSCRIPT
             11.2.8 LGC BIOSEARCH TECHNOLOGIES
             11.2.9 QUANTABIO
             11.2.10 RANDOX LABORATORIES LTD.
             11.2.11 NEW ENGLAND BIOLABS
             11.2.12 PCR BIOSYSTEMS
 
12 APPENDIX (Page No. - 589)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 
 
 
LIST OF TABLES (907 TABLES)
 
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 RISK ASSESSMENT ANALYSIS
TABLE 3 DPCR AND QPCR MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022)
TABLE 5 CONVENTIONAL PCR VS. QPCR & DPCR
TABLE 6 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 KEY TECHNOLOGIES
TABLE 8 COMPLEMENTARY TECHNOLOGIES
TABLE 9 ADJACENT TECHNOLOGIES
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023)
TABLE 11 AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023)
TABLE 12 DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS
TABLE 13 DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS
TABLE 14 DPCR AND QPCR MARKET: ROLE OF END USERS
TABLE 15 DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES
TABLE 16 PATENTS FILED, 2014–2024
TABLE 17 TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014–2024
TABLE 18 DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024−2025)
TABLE 19 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER
TABLE 21 IMPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSANDS)
TABLE 22 EXPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 23 IMPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
TABLE 24 EXPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)
TABLE 25 DPCR AND QPCR MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 26 QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 27 QPCR OFFERING MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 28 NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 32 MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 33 GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 35 QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 36 NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION,  2022–2029 (USD MILLION)
TABLE 41 GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 43 QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 44 INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019−2023
TABLE 45 QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 53 QPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 54 QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 58 LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 61 QPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 62 QPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 63 QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 65 EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 68 MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 69 GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 QPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 QPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 72 DPCR OFFERINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 73 DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 79 GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 81 DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 82 NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 85 LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 87 GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 88 DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 89 DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 90 DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 95 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 97 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 99 DPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 100 DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 102 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 103 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 106 GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 108 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 109 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 110 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 113 GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 114 BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 115 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 116 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 117 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 120 GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 122 NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 123 EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 124 ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 127 GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 DPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 129 DPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 130 DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 131 NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 134 LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 136 GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 DPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 138 DPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 139 QPCR AND DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 140 APPLICATION EXAMPLES OF QPCR
TABLE 141 QPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 142 QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 143 QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 144 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 147 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 148 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 151 NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 155 MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 156 GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 157 QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 158 NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 159 EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 161 LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 163 GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 164 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 165 NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 170 GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 171 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 172 NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 173 EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 177 GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 179 NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 180 EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 184 GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 186 QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 187 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 192 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 193 QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 194 NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)
TABLE 197 LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 198 MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 199 GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 200 QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 206 GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 207 QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 211 LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 213 GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 214 QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 221 QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 222 NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 223 EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 229 NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 230 EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 236 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 237 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 239 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 240 MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 DPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 245 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 250 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 251 DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 252 NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 257 GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 258 DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 259 NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)
TABLE 264 GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 265 DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 266 NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 267 EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)
TABLE 271 GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 272 DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION,  2022–2029 (USD MILLION)
TABLE 273 NORTH AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 EUROPE: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 ASIA PACIFIC: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 LATIN AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 MIDDLE EAST: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
TABLE 278 GCC COUNTRIES: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 279 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 280 NORTH AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 EUROPE: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 LATIN AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 MIDDLE EAST: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 285 GCC COUNTRIES: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 286 DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 287 DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 288 NORTH AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289 EUROPE: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 ASIA PACIFIC: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 291 LATIN AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 MIDDLE EAST: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)
TABLE 293 GCC COUNTRIES: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 294 DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 295 NORTH AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296 EUROPE: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 297 ASIA PACIFIC: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 298 LATIN AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 299 MIDDLE EAST: DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
TABLE 300 GCC COUNTRIES: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 301 DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION)
TABLE 302 NORTH AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303 EUROPE: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304 ASIA PACIFIC: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 305 LATIN AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 306 MIDDLE EAST: DPCR MARKET FOR GENE EXPRESSION, BY REGION,  2022–2029 (USD MILLION)
TABLE 307 GCC COUNTRIES: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 308 DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 309 NORTH AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 310 EUROPE: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 311 ASIA PACIFIC: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 312 LATIN AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 313 MIDDLE EAST: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 314 GCC COUNTRIES: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 315 DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 316 NORTH AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 317 EUROPE: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 318 ASIA PACIFIC: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 319 LATIN AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 320 MIDDLE EAST: DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 321 GCC COUNTRIES: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 322 DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)
TABLE 323 NORTH AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 324 EUROPE: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 325 ASIA PACIFIC: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 326 LATIN AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 327 MIDDLE EAST: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 328 GCC COUNTRIES: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 329 OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 330 NORTH AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 331 EUROPE: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 332 ASIA PACIFIC: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 333 LATIN AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 334 MIDDLE EAST: OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 335 GCC COUNTRIES: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 336 DPCR AND QPCR MARKET FOR END USERS, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 337 QPCR MARKET FOR END USERS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 339 NORTH AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 340 EUROPE: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 341 ASIA PACIFIC: QPCR FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 342 LATIN AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 343 MIDDLE EAST: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 344 GCC COUNTRIES: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 345 QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 346 NORTH AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 347 EUROPE: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 348 ASIA PACIFIC: QPCR FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 349 LATIN AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 350 MIDDLE EAST: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 351 GCC COUNTRIES: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 352 QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 353 NORTH AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 354 EUROPE: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 355 ASIA PACIFIC: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 356 LATIN AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 357 MIDDLE EAST: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 358 GCC COUNTRIES: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 359 QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 360 NORTH AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 361 EUROPE: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 362 ASIA PACIFIC: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 363 LATIN AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 364 MIDDLE EAST: QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 365 GCC COUNTRIES: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 366 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 367 NORTH AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 368 EUROPE: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 369 ASIA PACIFIC: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 370 LATIN AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 371 MIDDLE EAST: QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,  2022–2029 (USD MILLION)
TABLE 372 GCC COUNTRIES: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 373 QPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 374 NORTH AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 375 EUROPE: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 376 ASIA PACIFIC: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 377 LATIN AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 378 MIDDLE EAST: QPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 379 GCC COUNTRIES: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 380 DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 381 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 382 NORTH AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 383 EUROPE: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, 2022–2029 (USD MILLION)
TABLE 384 ASIA PACIFIC: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 385 LATIN AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 386 MIDDLE EAST: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 387 GCC COUNTRIES: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 388 DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 389 NORTH AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 390 EUROPE: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, 2022–2029 (USD MILLION)
TABLE 391 ASIA PACIFIC: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 392 LATIN AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 393 MIDDLE EAST: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY REGION, 2022–2029 (USD MILLION)
TABLE 394 GCC COUNTRIES: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 395 DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 396 NORTH AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 397 EUROPE: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 398 ASIA PACIFIC: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 399 LATIN AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 400 MIDDLE EAST: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 401 GCC COUNTRIES: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 402 DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 403 NORTH AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 404 EUROPE: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 405 ASIA PACIFIC: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 406 LATIN AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 407 MIDDLE EAST: DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION)
TABLE 408 GCC COUNTRIES: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 409 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 410 NORTH AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 411 EUROPE: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 412 ASIA PACIFIC: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 413 LATIN AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 414 MIDDLE EAST: DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 415 GCC COUNTRIES: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 416 DPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 417 NORTH AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 418 EUROPE: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 419 ASIA PACIFIC: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 420 LATIN AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 421 MIDDLE EAST: DPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 422 GCC COUNTRIES: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 423 DPCR AND QPCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 424 NORTH AMERICA: DPCR AND QPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 425 NORTH AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)
TABLE 426 NORTH AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 NORTH AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 NORTH AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 429 NORTH AMERICA: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)
TABLE 430 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 431 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 432 NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 433 NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 434 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 435 NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 NORTH AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 437 NORTH AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 438 NORTH AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 439 US: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 440 US: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 441 US: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 442 US: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 443 US: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 444 US: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 445 US: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 446 US: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 447 US: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 US: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 449 US: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 US: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 US: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 452 US: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 453 CANADA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 454 CANADA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 455 CANADA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 456 CANADA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 457 CANADA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 458 CANADA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 CANADA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 460 CANADA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 461 CANADA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 CANADA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 463 CANADA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 CANADA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 465 CANADA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 466 CANADA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 467 EUROPE: QPCR AND DPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 468 EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 469 EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 470 EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 471 EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 EUROPE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 475 EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 476 EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 477 EUROPE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 478 EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479 EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 480 EUROPE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 481 EUROPE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 482 GERMANY: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)
TABLE 483 GERMANY: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 GERMANY: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 GERMANY: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 486 GERMANY: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 487 GERMANY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 488 GERMANY: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 489 GERMANY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 490 GERMANY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 491 GERMANY: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 492 GERMANY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 493 GERMANY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 494 GERMANY: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 495 GERMANY: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 496 UK: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 497 UK: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498 UK: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499 UK: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 UK: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 501 UK: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 502 UK: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 503 UK: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 UK: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 UK: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 506 UK: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 507 UK: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 508 UK: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 509 UK: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 510 FRANCE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 511 FRANCE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 FRANCE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 513 FRANCE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514 FRANCE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 515 FRANCE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 516 FRANCE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 517 FRANCE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 518 FRANCE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 519 FRANCE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 520 FRANCE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 FRANCE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 FRANCE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 523 FRANCE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 524 ITALY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 525 ITALY: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 526 ITALY: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 527 ITALY: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 528 ITALY: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 529 ITALY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 ITALY: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 531 ITALY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 ITALY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 ITALY: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 534 ITALY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 535 ITALY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 536 ITALY: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 537 ITALY: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 538 SPAIN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 539 SPAIN: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 540 SPAIN: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 SPAIN: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 SPAIN: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 543 SPAIN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 SPAIN: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 545 SPAIN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 546 SPAIN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 547 SPAIN: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 548 SPAIN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 549 SPAIN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 550 SPAIN: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 551 SPAIN: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 552 REST OF EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 553 REST OF EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 554 REST OF EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 555 REST OF EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 556 REST OF EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557 REST OF EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 558 REST OF EUROPE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 559 REST OF EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 560 REST OF EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561 REST OF EUROPE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 562 REST OF EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 563 REST OF EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 564 REST OF EUROPE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 565 REST OF EUROPE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 566 ASIA PACIFIC: QPCR AND DPCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION)
TABLE 567 ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 568 ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 569 ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 570 ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 571 ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 572 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 573 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 574 ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 575 ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 576 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 577 ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 578 ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 579 ASIA PACIFIC: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 580 ASIA PACIFIC: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 581 CHINA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 582 CHINA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 583 CHINA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 584 CHINA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585 CHINA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586 CHINA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 587 CHINA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 588 CHINA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 589 CHINA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 590 CHINA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 591 CHINA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 592 CHINA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 593 CHINA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 594 CHINA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 595 JAPAN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 596 JAPAN: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 597 JAPAN: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 598 JAPAN: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 599 JAPAN: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 600 JAPAN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 601 JAPAN: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 602 JAPAN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 603 JAPAN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 604 JAPAN: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 605 JAPAN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 606 JAPAN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607 JAPAN: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 608 JAPAN: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 609 INDIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 610 INDIA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611 INDIA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 612 INDIA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 613 INDIA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 614 INDIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 615 INDIA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 616 INDIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 617 INDIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 618 INDIA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 619 INDIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 620 INDIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 621 INDIA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 622 INDIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 623 AUSTRALIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 624 AUSTRALIA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 625 AUSTRALIA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 626 AUSTRALIA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 627 AUSTRALIA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 628 AUSTRALIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 629 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 630 AUSTRALIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 631 AUSTRALIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 632 AUSTRALIA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 633 AUSTRALIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 634 AUSTRALIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 635 AUSTRALIA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 636 AUSTRALIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 637 SOUTH KOREA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 638 SOUTH KOREA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 639 SOUTH KOREA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 640 SOUTH KOREA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 641 SOUTH KOREA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 642 SOUTH KOREA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 643 SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 644 SOUTH KOREA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 645 SOUTH KOREA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 646 SOUTH KOREA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 647 SOUTH KOREA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 648 SOUTH KOREA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 649 SOUTH KOREA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 650 SOUTH KOREA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 651 REST OF ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)
TABLE 652 REST OF ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 653 REST OF ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)
TABLE 654 REST OF ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 655 REST OF ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 656 REST OF ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 657 REST OF ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 658 REST OF ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 659 REST OF ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 660 REST OF ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 661 REST OF ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 662 REST OF ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 663 REST OF ASIA PACIFIC: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 664 REST OF ASIA PACIFIC: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 665 LATIN AMERICA: QPCR AND DPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 666 LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)
TABLE 667 LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 668 LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 669 LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 670 LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 671 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 672 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 673 LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 674 LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 675 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 676 LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 677 LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 678 LATIN AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 679 LATIN AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 680 BRAZIL: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 681 BRAZIL: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 682 BRAZIL: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 683 BRAZIL: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 684 BRAZIL: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 685 BRAZIL: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 686 BRAZIL: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 687 BRAZIL: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 688 BRAZIL: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 689 BRAZIL: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 690 BRAZIL: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 691 BRAZIL: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 692 BRAZIL: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 693 BRAZIL: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 694 MEXICO: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 695 MEXICO: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 696 MEXICO: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 697 MEXICO: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 698 MEXICO: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 699 MEXICO: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 700 MEXICO: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 701 MEXICO: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 702 MEXICO: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 703 MEXICO: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 704 MEXICO: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 705 MEXICO: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)
TABLE 706 MEXICO: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 707 MEXICO: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 708 REST OF LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 709 REST OF LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 710 REST OF LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 711 REST OF LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 712 REST OF LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 713 REST OF LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)
TABLE 714 REST OF LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 715 REST OF LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 716 REST OF LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 717 REST OF LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 718 REST OF LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 719 REST OF LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 720 REST OF LATIN AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 721 REST OF LATIN AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 722 MIDDLE EAST: DPCR AND QPCR MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 723 MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 724 MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 725 MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 726 MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 727 MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 728 MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 729 MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 730 MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 731 MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 732 MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 733 MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 734 MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 735 MIDDLE EAST: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 736 MIDDLE EAST: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 737 GCC COUNTRIES: DPCR AND QPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 738 GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 739 GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 740 GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 741 GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 742 GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 743 GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)
TABLE 744 GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 745 GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 746 GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 747 GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 748 GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 749 GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 750 GCC COUNTRIES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 751 GCC COUNTRIES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 752 KINGDOM OF SAUDI ARABIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 753 KINGDOM OF SAUDI ARABIA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 754 KINGDOM OF SAUDI ARABIA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 755 KINGDOM OF SAUDI ARABIA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 756 KINGDOM OF SAUDI ARABIA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 757 KINGDOM OF SAUDI ARABIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 758 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 759 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 760 KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 761 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
TABLE 762 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 763 KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 764 KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY END USER,  2022–2029 (USD MILLION)
TABLE 765 KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 766 UNITED ARAB EMIRATES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 767 UNITED ARAB EMIRATES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 768 UNITED ARAB EMIRATES: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 769 UNITED ARAB EMIRATES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 770 UNITED ARAB EMIRATES: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 771 UNITED ARAB EMIRATES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 772 UNITED ARAB EMIRATES: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 773 UNITED ARAB EMIRATES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 774 UNITED ARAB EMIRATES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 775 UNITED ARAB EMIRATES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 776 UNITED ARAB EMIRATES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 777 UNITED ARAB EMIRATES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 778 UNITED ARAB EMIRATES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 779 UNITED ARAB EMIRATES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 780 OTHER GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 781 OTHER GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 782 OTHER GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 783 OTHER GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 784 OTHER GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 785 OTHER GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 786 OTHER GCC COUNTRIES: QPCR MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
TABLE 787 OTHER GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 788 OTHER GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 789 OTHER GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 790 OTHER GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 791 OTHER GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 792 OTHER GCC COUNTRIES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 793 OTHER GCC COUNTRIES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 794 REST OF MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 795 REST OF MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 796 REST OF MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 797 REST OF MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 798 REST OF MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 799 REST OF MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)
TABLE 800 REST OF MIDDLE EAST: QPCR MARKET, BY APPLICATION,  2022–2029 (USD MILLION)
TABLE 801 REST OF MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 802 REST OF MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 803 REST OF MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 804 REST OF MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 805 REST OF MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 806 REST OF MIDDLE EAST: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 807 REST OF MIDDLE EAST: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 808 AFRICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 809 AFRICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 810 AFRICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 811 AFRICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 812 AFRICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 813 AFRICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 814 AFRICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 815 AFRICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 816 AFRICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 817 AFRICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 818 AFRICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 819 AFRICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 820 AFRICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 821 AFRICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 822 DPCR AND QPCR MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES
TABLE 823 DPCR AND QPCR MARKET: DEGREE OF COMPETITION
TABLE 824 DPCR AND QPCR MARKET: OFFERING FOOTPRINT
TABLE 825 DPCR AND QPCR MARKET: APPLICATION FOOTPRINT
TABLE 826 DPCR AND QPCR MARKET: END-USER FOOTPRINT
TABLE 827 DPCR AND QPCR MARKET: REGION FOOTPRINT
TABLE 828 DPCR AND QPCR MARKET: KEY STARTUPS/SMES
TABLE 829 DPCR AND QPCR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 830 DPCR AND QPCR MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−MAY 2024
TABLE 831 DPCR AND QPCR MARKET: DEALS, JANUARY 2021–MAY 2024
TABLE 832 DPCR AND QPCR MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 833 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 834 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 835 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024
TABLE 836 DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2024
TABLE 837 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 838 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 839 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024
TABLE 840 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–MAY 2024
TABLE 841 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 842 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 843 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 844 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024
TABLE 845 MERCK KGAA: COMPANY OVERVIEW
TABLE 846 MERCK KGAA: PRODUCTS OFFERED
TABLE 847 QIAGEN N.V.: COMPANY OVERVIEW
TABLE 848 QIAGEN N.V.: PRODUCTS OFFERED
TABLE 849 QIAGEN N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 850 QIAGEN N.V.: DEALS, JANUARY 2021–MAY 2024
TABLE 851 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 852 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 853 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 854 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–MAY 2024
TABLE 855 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 856 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 857 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 858 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–MAY 2024
TABLE 859 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 860 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 861 TAKARA BIO INC.: DEALS, JANUARY 2021–MAY 2024
TABLE 862 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 863 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 864 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 865 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2024
TABLE 866 ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 867 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 868 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 869 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 870 PROMEGA CORPORATION: PRODUCTS OFFERED
TABLE 871 PROMEGA CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 872 MERIDIAN BIOSCIENCE: COMPANY OVERVIEW
TABLE 873 MERIDIAN BIOSCIENCE: PRODUCTS OFFERED
TABLE 874 MERIDIAN BIOSCIENCE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 875 MERIDIAN BIOSCIENCE: DEALS, JANUARY 2021–MAY 2024
TABLE 876 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
TABLE 877 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCTS OFFERED
TABLE 878 ENDRESS+HAUSER GROUP SERVICES AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 879 ENDRESS+HAUSER GROUP SERVICES AG: DEALS, JANUARY 2021–MAY 2024
TABLE 880 BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 881 BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 882 BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 883 EPPENDORF AG: COMPANY OVERVIEW
TABLE 884 EPPENDORF AG: PRODUCTS OFFERED
TABLE 885 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
TABLE 886 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 887 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
TABLE 888 QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–MAY 2024
TABLE 889 ENZO BIOCHEM INC.: COMPANY OVERVIEW
TABLE 890 ENZO BIOCHEM INC.: PRODUCTS OFFERED
TABLE 891 ENZO BIOCHEM INC.: DEALS, JANUARY 2021–MAY 2024
TABLE 892 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 893 LEPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 894 SYSMEX CORPORATION: COMPANY OVERVIEW
TABLE 895 SYSMEX CORPORATION: PRODUCTS OFFERED
TABLE 896 BIOCARTIS: COMPANY OVERVIEW
TABLE 897 STILLA: COMPANY OVERVIEW
TABLE 898 ANTYLIA SCIENTIFIC: COMPANY OVERVIEW
TABLE 899 BIONEER CORPORATION: COMPANY OVERVIEW
TABLE 900 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 901 SEEGENE INC.: COMPANY OVERVIEW
TABLE 902 GENSCRIPT: COMPANY OVERVIEW
TABLE 903 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
TABLE 904 QUANTABIO: COMPANY OVERVIEW
TABLE 905 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
TABLE 906 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
TABLE 907 PCR BIOSYSTEMS: COMPANY OVERVIEW
 
 
LIST OF FIGURES (58 FIGURES)
 
FIGURE 1 REGIONAL SEGMENTATION
FIGURE 2 RESEARCH DESIGN METHODOLOGY
FIGURE 3 DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES
FIGURE 4 DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023)
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 9 DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024–2029
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 12 DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET
FIGURE 18 RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD
FIGURE 19 QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
FIGURE 20 EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD
FIGURE 21 DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 23 DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 SUPPLY CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES
FIGURE 26 AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021−2023)
FIGURE 27 DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS
FIGURE 28 NUMBER OF PATENTS GRANTED, 2014–2024
FIGURE 29 TOP TEN PATENT APPLICANTS, 2014–2024
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
FIGURE 32 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
FIGURE 33 ASIA PACIFIC: DPCR & QPCR MARKET SNAPSHOT
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2019−2023 (USD MILLION)
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
FIGURE 36 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 37 DPCR AND QPCR MARKET: OVERALL FOOTPRINT
FIGURE 38 DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 39 EV/EBITDA OF KEY DPCR AND QPCR VENDORS
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY DPCR AND QPCR VENDORS
FIGURE 41 BRAND/PRODUCT COMPARISON ANALYSIS, BY DPCR AND QPCR OFFERINGS
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 46 QIAGEN N.V.: COMPANY SNAPSHOT (2023)
FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 50 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)
FIGURE 51 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
FIGURE 52 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY SNAPSHOT (2023)
FIGURE 53 BIOMÉRIEUX: COMPANY SNAPSHOT (2023)
FIGURE 54 EPPENDORF AG: COMPANY SNAPSHOT (2023)
FIGURE 55 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 56 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
FIGURE 57 LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 58 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)

 

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global digital PCR (dPCR) and real-time PCR (qPCR) market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the digital PCR (dPCR) and real-time PCR (qPCR) market. The secondary sources used for this study include World Bank, GLOBOCAN, World Health Organization (WHO), Eurostat, International Trade Administration, National Human Genome Research Institute (NHGRI, US), National Institutes of Health (NIH) (US), Institute for Health Metrics and Evaluation (US), US Food and Drug Administration (US FDA), Health Canada, European Medicines Agency (UK), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), German Cancer Research Center, NHS (UK), Medicines and Healthcare Products Regulatory Agency (UK), Pharmaceuticals and Medical Devices Agency (Japan), Beijing Institute of Genomics (China), Ministry of Science & Technology (India), Ministry of Food and Drug Safety (South Korea), BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global digital PCR (dPCR) and real-time PCR (qPCR) market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the digital PCR (dPCR) and real-time PCR (qPCR) market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the market have been identified through extensive secondary research.
  • The revenues generated from the digital PCR (dPCR) and real-time PCR (qPCR) business of leading players have been determined through primary and secondary research to arrive at the overall digital PCR (dPCR) and real-time PCR (qPCR) market.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • Additionally, to arrive at the digital PCR (dPCR) and real-time PCR (qPCR) market for product segments, the PCR business shares of leading players for separate product category (wherever available) were also gathered from secondary sources. In some instances, the shares of PCR product businesses were ascertained through a detailed analysis of various parameters, including product portfolios, market positioning and primary insights.
  • All assumptions, approaches and individual shares/revenue estimates were validated through expert interviews.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Polymerase chain reaction (PCR) is a well-established technique used for the in vitro amplification of a given nucleotide (such as DNA). Digital polymerase chain reaction (digital PCR or dPCR) is a third-generation polymerase chain reaction technique that is used to clonally amplify and directly quantify nucleic acid strands, including DNA, cDNA, or RNA. Similarly, quantitative/real-time PCR (qPCR) is a well-established PCR technique that is widely utilized in DNA identification, amplification, and quantification. It involves the real-time analysis of reaction mixtures with the aid of fluorescent markers that are specific to either the end product or the reactant.

Stakeholders

  • dPCR and qPCR product manufacturing companies
  • Third-party suppliers, direct suppliers, distributors, and channel partners
  • Venture capitalists and other public-private funding agencies
  • Healthcare service providers (including hospitals and diagnostic centers)
  • Pharmaceutical and biotechnology companies
  • Academic and research institutes
  • CROs & CDMOs
  • Forensic laboratories
  • Market research and consulting firms
  • Government and independent regulatory authorities

Report Objectives

  • To define, describe, and forecast the digital PCR (dPCR) and real-time PCR (qPCR) market based on offering, application, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall digital PCR (dPCR) and real-time PCR (qPCR) market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players in the digital PCR (dPCR) and real-time PCR (qPCR) market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the digital PCR (dPCR) and real-time PCR (qPCR) market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the digital PCR (dPCR) and real-time PCR (qPCR) market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific Digital PCR (dPCR) and real-time PCR (qPCR) market into countries
  • A further breakdown of the Rest of European Digital PCR (dPCR) and real-time PCR (qPCR) market into countries
  • A further breakdown of the Rest of Latin American Digital PCR (dPCR) and real-time PCR (qPCR) market into countries
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 3161
Published ON
Jul, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital PCR (dPCR) and Real-time PCR (qPCR) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback